Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy

Fig. 3

Stratified Analysis of Serum lncRNA GAS5 and miR-21 in Relation to Clinical and Pathological Parameters in Patients with DN. (A) The expression of serum lncRNA GAS5. aP<0.05 vs. the 3.5 g ≤ 24 h UTP < 8.0 g group; B was the expression of serum miR-21 in various renal biopsy pathological grades. aP<0.05 vs. the IIb group

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us